CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's Lymphoma - Related Studies

CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's Lymphoma

This study is ongoing, but not recruiting participants.

Study NCT00455897. Last updated on October 6, 2008. Information provided by Massachusetts General Hospital

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Lymphoma, Non-Hodgkin
		Lymphoma, B-Cell
		Lymphoma, Diffuse

2	Additional conditions recognized in this trial
		Lymphoma

3	More general conditions related to this trial
		Immune System Diseases
		Immunoproliferative Disorders
		Lymphatic Diseases
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type

4	Interventions listed in this trial
		GM-CSF
		CHOP
		Rituximab

5	More general drug interventions related to this trial
		Antineoplastic Agents
		Antirheumatic Agents
		Immunologic Factors
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

6	Sponsors listed in this trial
		Massachusetts General Hospital
		Beth Israel Deaconess Medical Center
		Brigham and Women's Hospital
		Dana-Farber Cancer Institute
		Bayer